IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) is scheduled to announce its earnings results before the market opens on Tuesday, August 6th. Analysts expect the company to announce earnings of $2.87 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
IDEXX Laboratories Stock Performance
NASDAQ IDXX opened at $468.63 on Monday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.16 and a current ratio of 1.57. The company has a market capitalization of $38.70 billion, a PE ratio of 45.37, a price-to-earnings-growth ratio of 3.91 and a beta of 1.32. IDEXX Laboratories has a 52-week low of $372.50 and a 52-week high of $583.39. The company has a 50-day simple moving average of $489.02 and a 200 day simple moving average of $514.82.
Insiders Place Their Bets
In related news, Director Bruce L. Claflin sold 200 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $540.80, for a total transaction of $108,160.00. Following the completion of the transaction, the director now owns 161 shares of the company’s stock, valued at $87,068.80. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 2.11% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on IDEXX Laboratories
About IDEXX Laboratories
IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Read More
- Five stocks we like better than IDEXX Laboratories
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- With Risk Tolerance, One Size Does Not Fit All
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- What is the Dogs of the Dow Strategy? Overview and Examples
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.